Evidence map›Paper›PMID 41361534›Full record

ArticleProstate cancer and prostatic diseases2026

Deep learning algorithm assisting diagnosis of prostate cancer extracapsular extension based on [

Fei Yao, Dongqin Zhu, Heng Lin, Cunke Miao, Qi Lin, Tiancheng Li, Yuandi Zhuang, Shuying Bian, Yunjun Yang, Jie Lin and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Prostate cancer and prostatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. The value of [Quantitative imaging in medicine and surgery · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fei Yao *The Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.ORCID http://orcid.org/0000-0002-4577-3264
Dongqin Zhu *The Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Heng LinThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Cunke MiaoThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Qi LinThe Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Tiancheng LiThe Department of Nuclear Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310000, China.
Yuandi ZhuangThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Shuying BianThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Yunjun YangThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Jie LinThe Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Kehua PanThe Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China. pankehua@wmu.edu.cn.ORCID http://orcid.org/0009-0009-6040-9063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to develop and validate deep learning (DL) models based on multiparametric MRI (mpMRI) and [

methodsA total of 388 patients who underwent radical prostatectomy were enrolled from centers A, B and C. Three DL models based on mpMRI, PET/CT, and a combined MPC model were developed and compared with a manual model based on the ECE grading system. Additionally, three combined models (mpMRI-M, PET/CT-M, and MPC-M) were constructed by integrating the DL models with the Manual model. To enhance clinical applicability, an easy model (E-MPC-M) was developed. Model performance was evaluated using the area under the receiver-operating-characteristic curve (AUC) and metrics derived from the confusion matrix. Gradient-weighted class-activation-mapping (Grad-CAM) was employed to visualize model interpretability.

resultsIn the internal cohort, the Manual, MPC, and MPC-M models achieved AUCs of 0.752, 0.897, and 0.907, respectively; corresponding sensitivities were 0.616, 0.896, and 0.915, and specificities were 0.791, 0.740, and 0.802. In the external validation cohort, these models achieved AUCs of 0.665, 0.824, and 0.849; sensitivities of 0.318, 0.955, and 0.955; and specificities of 0.960, 0.600, and 0.640, respectively. The E-MPC-M model also showed robust performance, with an AUC of 0.862 in the internal cohort and 0.775 in the external cohort. Grad-CAM visualizations highlighted the model's focus on tumor-relevant regions, confirming effective learning of tumor features.

conclusionsThe MPC-M model demonstrated strong predictive performance for PCa ECE across internal and external cohorts, while the E-MPC-M model retained much of this performance with enhanced clinical practicality. However, these models should be considered as preliminary, and larger prospective multicenter studies are required to confirm their robustness and generalizability.

Indexed as

Deep LearningMultiparametric Magnetic Resonance ImagingOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedAlgorithmsExtranodal ExtensionFluorine RadioisotopesHumansMaleMiddle AgedNiacinamideProstatectomyROC CurveFluorine RadioisotopesNiacinamideOligopeptidesPSMA-1007

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.